ArticleRheumatology international2014

Serum macrophage migration inhibitory factor levels are correlated with response to tocilizumab therapy in patients with rheumatoid arthritis.

Tsuyoshi Kasama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.